AstraZeneca has always believed in science, inspires infinite possibilities, and puts science at the top of all work. AstraZeneca's strategically important core treatment areas, and are committed to exploring pathogenic mechanisms, treatment methods, and innovative drugs, so that science can change people's lives and bring it to the medical industry Significant changes.

Mylan Specialty is a pharmaceutical manufacturing company. They develop, manufacture, and market prescription drug products for the treatment of respiratory diseases, severe allergic reactions, and psychiatric disorders.

Arakis Limited is focuses on discovery and development of inflammatory diseases and oncology adjunctive therapy. The company's research capability specializes in the cytokine and receptor mediated mechanisms of disease. The company identifies, develops, and commercializes product opportunities based upon new clinical uses for known drugs or known drug templates, as well as termed performance enhanced medicines.

Xiangyu Pharmaceutical Co., Ltd. engages in manufacturing, research and development and sales of Chinese and western medicines. It offers red blood enriching oral liquid and ibuprofen suspension. The company was founded on October 23, 2000 and is headquartered in Linyi, China.

Henan Zhonghua Chinese Medical Museum Co., Ltd., established on 2020-06-05, Business scope includes general items:Chinese Medicine Clinic Services(Business activities must be filed with the competent department of traditional Chinese medicine);hospital management;Class I Medical Device Leasing;Class II Medical Device Leasing;Health Consulting Services(Does not include medical services);Health Care Services(non-medical);Pension Service;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Information Consulting Service(Not including licensing information consulting services);Business Management Consulting;market survey(Does not include foreign investigations);Educational Consulting Services(Education and training activities that do not include licensing approval);Commercial Complex Management Services;Conference and Exhibition Services;Organize cultural and artistic exchange activities;Graphic design and production;real estate herbal medicine(Does not contain Chinese herbal medicine)buy and sell;Sales of daily chemical products;Disinfectant sales(Free of Hazardous Chemicals);Purchase of primary agricultural products;food sales(Only sell prepackaged food);Healthy food(prepackaged)Sales;Sales of Class I Medical Devices;Sales of Class II Medical Devices;General merchandise sales;Cosmetics Retail(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:medical service;Chinese Herbal Pieces Decoction Service;Life beauty service;Medical beauty service;Class III Medical Device Leasing;Drug internet information service;Drug retail;food sales;Class III medical device business(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

Zhengzhou Ajisen Biotechnology Co., Ltd., established on 2016-08-15, Business scope includes biological extracts,Pharmaceutical Auxiliary,Research and sales of pharmaceutical intermediates;technology development in biotechnology,technical consulting,Technology Transfer and Technical Services;Sales:Pre-packaged food,Health Supplies,Laboratory equipment and consumables;the first sort,R&D of Class II Medical Devices,Production,Sales.

Hangzhou Zhilian Technology Co., Ltd., established on 2018-12-20, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Remote Health Management Services;Health Consulting Services(Does not include medical services);internet sales(Except for products that require a license for sale);internet data service;Internet Security Services;Computer System Services;Information Consulting Service(Not including licensing information consulting services);Information Technology Consulting Services;Internet of things technology research and development;Internet of Things Technology Services;IoT application service;data processing services;software development;Data processing and storage support services;AI Hardware Sales;Communication equipment sales;Computer and communication equipment rental;Sales of Class I Medical Devices;Sales of Class II Medical Devices;hospital management;advertisement making;advertising(non-broadcasting station,television station,Newspaper Publishing Unit);Advertising Design,acting;Conference and Exhibition Services;market survey(Does not include foreign investigations);marketing planning;Ticket agency service;Camera and Video Production Services;Film Production Services(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).licensed items:Class III medical device business;Food Internet Sales(Selling prepackaged food);Publications Internet Sales;The second type of value-added telecommunications services(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).

Hangzhou Enshi Jiyin Technology Development Co. Ltd., part of Shanxi C&Y Pharmaceutical Group Co., Ltd., is a Chinese company located in Hangzhou. The firm engages in bio-technology development. Xue Min Zuo has been the CEO since 2014. Shanxi C&Y Pharmaceutical Group Co., Ltd. acquired Hangzhou Enshi Jiyin Technology Development Co. Ltd. on December 26, 2014 for $16.29 million.

Elan Pharma International Ltd., a subsidiary of Perrigo Co. Plc, is a company headquartered in South San Francisco, CA, that develops, manufactures and distributes pharmaceutical products.

Boehringer Ingelheim International GmbH manufactures pharmaceutical prodcuts. It offers human and animal health products. The company was founded by Albert Boehringer in 1885 and is headquartered in Ingelheim, Germany.

Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines to treat patients with serious or life-threatening medical conditions. It creates multiple products on the market and a development pipeline. The company became a member of the Roche Group in 2009. As part of their merger agreement, Roche and Genentech combined their pharmaceutical operations in the United States. Genentech’s South San Francisco campus now serves as the headquarters for Roche pharmaceutical operations in the United States. Genentech’s Research and Early Development section operates as an independent center within Roche. Genentech was founded in 1976 by [Robert Swanson](https://www.crunchbase.com/person/robert-a-swanson) and [Herbert Boyer](https://www.crunchbase.com/person/herbert-w-boyer). It is headquartered in South San Francisco, C.A.

Venturepharma, Inc. manufactures pharmaceutical products. It offers VP discovery, API development and outsourcing, biopharmaceuticals discovery, RX and OTC. The firm provides products for oncology, CNS, dermnova, diabetes, cardiovascular, respiration and vaccine. The company was founded in 1998 and is headquartered in Haidian, China.

New Target (Shanghai) Molecular Medical Technology Co., Ltd., established on 2005-09-27, Business scope includes molecular medical technology,Technology development in the field of data analysis software,technical consulting,technology transfer,Technical Services,Engaged in the import and export of goods and technology. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Jingmen No. 2 People's Hospital is a private company headquartered in Jingmen, China. The firm engages in providing general medical and surgical services and other hospital services.